A SBIR Phase II contract was awarded to Creare in July, 2020 for $545,486.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.
The proposed low-SWaP PAPR technology improves the convenience, comfort, and protection level for respirators used in low-threat hazardous environments. Creare’s PAPR technology will be applicable to a variety of respiratory protection needs, including emergency escape, laboratory and field work in low-hazard conditions, and some combat and combat support activities. The PAPR will improve user functionality, task performance, and task duration.